Qiaoling Zhang
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape.
Journal: Frontiers in cell and developmental biology
Published: May 27, 2025
Cancer-associated fibroblasts secreting IL-6 inhibit the cisplatin and docetaxel killing effect in lung squamous cell carcinoma.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 30, 2025
Corrigendum to "CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression" [Biochim. Biophys. Acta Mol. Basis Dis., 1868 (2022) 166521-166521/10.1016/j.bbadis.2022.166521].
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 26, 2025
CAFs mediate carboplatin resistance in LUAD via CXCL12 secretion regulated by NF-κB activation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 06, 2025
Research progress of interaction between CAFs and M2 macrophages to promote tumor progression
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: January 29, 2024
CD248-expressing cancer-associated fibroblasts induce non-small cell lung cancer metastasis via Hippo pathway-mediated extracellular matrix stiffness.
Journal: Journal of cellular and molecular medicine
Published: November 02, 2023
IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer.
Journal: Journal of cellular and molecular medicine
Published: July 08, 2023
CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 18, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026